BTC$60,654.00-0.59%
ETH$1,559.10-1.26%
USDT$0.9996-0.01%
BNB$573.34+0.04%
USDC$0.9997+0.01%
XRP$1.09-1.35%
SOL$61.91-3.12%
TRX$0.3237+0.86%
FIGR_HELOC$1.03+0.46%
DOGE$0.0814-0.42%
HYPE$56.44-5.27%
USDS$0.9997-0.02%
LEO$9.44-1.44%
RAIN$0.0128-1.63%
XLM$0.2116+5.14%
CC$0.1627+9.72%
BTC$60,654.00-0.59%
ETH$1,559.10-1.26%
USDT$0.9996-0.01%
BNB$573.34+0.04%
USDC$0.9997+0.01%
XRP$1.09-1.35%
SOL$61.91-3.12%
TRX$0.3237+0.86%
FIGR_HELOC$1.03+0.46%
DOGE$0.0814-0.42%
HYPE$56.44-5.27%
USDS$0.9997-0.02%
LEO$9.44-1.44%
RAIN$0.0128-1.63%
XLM$0.2116+5.14%
CC$0.1627+9.72%
Spotify’s impressive growth tripped over higher personnel costs. Is this a temporary stumble or a prime buying opportunity?
Fundamental Global announces $200 million private placement to launch Ethereum treasury strategy, causing stock to surge 76.66% in premarket trading.
For near-future practical quantum computing, these companies offer relatives safe exposure. And some more than others.
Novo Nordisk stock crashed over 20% in premarket trading after the company cut its 2025 forecast for the second time.
VAPE stock surged in premarket trading following the announcement of a PIPE offering to establish the world's largest publicly listed BNB treasury strategy.
As Intel advances its restructuring efforts, market volatility and noisy stock signals are to be expected.
Intel shares plummeted in premarket trading after reporting Q2 EPS of -$0.10, missing expectations by 171.81%.
Similar in spirit to memecoins, these stocks ride the waves of surges and crashes.
Dow Inc. reported a massive Q2 loss of $0.42 per share versus expectations of a $0.12 loss, prompting a 50% dividend cut.
American Airlines shares tumbled over 6% in premarket trading despite beating Q2 earnings expectations, as investors reacted negatively to disappointing third-quarter guidance and reduced full-year profit…
Exposure to Lockheed Martin represents exposure to U.S. hegemony maintenance.
Fiserv stock plunged over 16% despite beating Q2 earnings expectations, as the company lowered its full-year organic revenue growth guidance and showed weakness in its merchant…
Abivax shares surged over 400% in premarket trading after announcing positive Phase 3 results for its ulcerative colitis drug obefazimod.